have us call you right now.
Case Study
From rough estimates to precise action: CO2 footprinting for Gilde Healthcare
A CONVERSATION WITH
Gilde Healthcare is a leading European private equity firm focused on healthcare investments, supporting innovative companies that improve patient outcomes and healthcare efficiency.
Private Equity
1982
150-200
Utrecht, The Netherlands
Private equity investments in healthcare, life sciences, and medical technology
Gilde Healthcare needed comprehensive CO2 footprint calculations for two of their private equity portfolio companies to meet regulatory requirements and sustainability goals.
Key questions they faced:
- Where are the biggest emission sources across their portfolio? 
- How to comply with upcoming CSRD regulations? 
- What methodology works best for private equity: spend-based or activity-based analysis? 
- Led comprehensive footprint calculation using spend-based methodology for both portfolio companies 
- Built internal capacity through hands-on training and knowledge transfer 
- Defined clear scope and strategy in collaboration with Regreener's experts 
- Prioritized complex supplier emissions - the key challenge for private equity portfolios 
- Collected primary data from main suppliers; used reliable estimates when data unavailable 
- Delivered complete emissions overview across all relevant scopes, aligned with GHG Protocol standards 
- Enhanced accuracy: precise carbon footprint measurements based on actual operational data, replacing rough industry estimate 
- Strategic insights: clear understanding of emission sources with actionable reduction opportunities for each portfolio company 
- Competitive advantage: better ESG metrics and sustainability credentials for portfolio companies and Gilde Healthcare 
- Scalable expertise: portfolio teams equipped with knowledge and frameworks for ongoing sustainability improvements across all investments 





